Form 4 for ADPT Adaptive Biotechnologies Corp
Accepted 2022-03-08 00:00:00 ET · period of report 2022-03-04 · accession 0001209191-22-017393 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-08 | 2022-03-04 | ADPT | ROBINS CHAD M | CEO, COB, Dir | A - Grant | $0.00 | +247.1K | 1.92M | +15% | $0 | |
| 2022-03-08 | 2022-03-07 | ADPT | ROBINS CHAD M | CEO, COB, Dir | S - Sale | $12.01 | -4,424 | 1.92M | -0.2% | -$53.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-04 | A | A | 247,117 | $0.00 | 1,920,578 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-07 | S | D | 4,424 | $12.01 | 1,916,154 | D | — | — |